Forte Biosciences, Inc. vs Aardvark Therapeutics, Inc., risk disclosures compared

2topics both disclose

4only Forte Biosciences, Inc.

4only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Forte Biosciences, Inc.	Aardvark Therapeutics, Inc.
Business Continuity	24	7
Ransomware	8	4

Only Forte Biosciences, Inc.

Topic	Filings
Internal Control	9
Restatement	6
Material Weakness	4
Enforcement Action	3

Only Aardvark Therapeutics, Inc.

Topic	Filings
Cross Border Data Transfer	3
Data Residency	3
Audit Committee Oversight	2
ESG Reporting	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Forte Biosciences, Inc. · Aardvark Therapeutics, Inc. · All companies